Agent Approved for Highly Toxic Chemotherapy Levels

The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that...

Read More

For latest news and updates
Email-id is invalid